Related Subjects:
|Hypercalcaemia
|Neutropenic Sepsis
|Pulmonary Embolism
|Superior vena caval obstruction syndrome
|Cerebral Metastases
|Metastatic bone disease
|Oncological emergencies
π Brain Metastases are the most common intracranial tumours in adults. Whole-brain radiotherapy remains a key treatment, though management is increasingly tailored with surgery and stereotactic radiosurgery.
π About
- π« Lung cancer is the most frequent cause of brain metastases.
- Other common primaries: breast, kidney, melanoma, testicular tumours, and colorectal cancers.
- 80% occur in the cerebral hemispheres; ~20% are posterior fossa.
- Typically lodge at the greyβwhite junction or watershed zones (MCAβPCA borders).
𧬠Aetiology
- Hematogenous spread, with tumour emboli seeding cortical and subcortical vessels.
- Predilection for vascular junctions due to abrupt calibre change in vessels.
- Histologies prone to haemorrhage: melanoma, choriocarcinoma, lung, thyroid, renal carcinoma.
π Common Primary Sources
- π« Lung cancer
- π©βπΌ Breast cancer (esp. ductal type β cerebellar deposits)
- π§ͺ Testicular germ cell tumours
- π©Έ Renal cell carcinoma
- π€ Malignant melanoma
- Less common: colorectal, ovarian, prostate, thyroid
π Location Tendencies
- Breast/prostate/myeloma β skull & dura
- Pelvic/colonic tumours β posterior fossa
- Renal cell / melanoma β haemorrhagic secondaries
π©Ί Clinical Features
- Headache, nausea/vomiting (raised ICP, oedema).
- Seizures (new-onset seizure in adult = red flag π¨).
- Focal deficits: weakness, speech disturbance, visual field loss.
- Cerebellar involvement β ataxia, nystagmus.
- Stroke-like presentation (ischaemic/haemorrhagic mimic).
π§ͺ Investigations
- MRI (gold standard): Multiple circumscribed lesions with vasogenic oedema; better than CT for posterior fossa.
- CT with contrast: Detects most >1 cm lesions, useful acutely.
- Solitary lesion: Always consider a primary brain tumour until proven otherwise.
π Searching for a Primary
- Skin exam β melanoma.
- Thyroid palpation/USS.
- Breast exam Β± mammography.
- CT chest/abdomen/pelvis β lung, renal, GI primaries.
- Tumour markers: CEA, LFTs.
- Bone scan for skeletal metastases.
- GI endoscopy if indicated.
π Management
- Depends on number of lesions, systemic disease burden, and performance status.
- Corticosteroids: Dexamethasone rapidly reduces oedema & improves symptoms π―.
- Anticonvulsants: Levetiracetam preferred for seizure prophylaxis.
- Surgery: For solitary, accessible lesions in good surgical candidates.
- Radiotherapy: Whole-brain radiotherapy (WBRT) for multiple lesions; stereotactic radiosurgery (SRS) for limited deposits.
- Chemotherapy: Limited CNS penetration but used in sensitive primaries (e.g. germ cell tumours, small cell lung cancer).
- MDT input (neurosurgery, oncology, palliative care) is essential for individualized treatment planning.
π Prognosis
- Median survival historically 3β6 months; improved with SRS and modern therapies.
- Best prognosis: solitary metastasis, controlled primary, good performance status.
- End-of-life care is an important consideration in advanced systemic disease.